goBalto is the industry leader in cloud-based study startup software for the global life sciences industry, offering the only complete end-to-end platform for starting clinical trials, from site identification, feasibility assessment and selection through to activation, with comprehensive metrics to track adherence to timelines and budget. Committed to accelerating clinical trials through innovation, product excellence, and customer success, goBalto works with four of the top five CROs and more than two-thirds of the top 25 pharmas. Our customers include: Allergan, Clinipace, Covance, CMIC HOLDINGS, Genentech Roche, ICON, Novartis, PSI CRO, Syneos Health, TFS International, and Worldwide Clinical Trials. goBalto is headquartered in San Francisco, with offices in Philadelphia and Singapore. For more information, visit www.gobalto.com


goBalto Select: Optimizing site selection goBalto Select: Optimizing site selection

Open sites on time and meet enrollment targets. With a data-oriented approach to weighing selection and performance variables sponsors and CROs can now identify study sites and target populations ideally suited to studies.

goBalto Activate: Driving site activation goBalto Activate: Driving site activation

Activate is the industry’s first purpose-built software-as-service (SaaS) application that enables sponsors, CROs, and sites to get studies started in the shortest time possible. Hosted in the cloud, Activate provides anytime, anywhere access to site activation status metrics and data.

goBalto Analyze: Leveraging business intelligence goBalto Analyze: Leveraging business intelligence

If you use goBalto Activate for study startup, you have a wealth of data for sites, study countries, and study document and submission activities that you can use in reports and analytics.



717 Market Street, Suite 500

San Francisco, CA 94103


Phone: 415.671.4372

Contact: Craig Morgan


  • GoBalto Accelerating Clinical Trials
    GoBalto Accelerating Clinical Trials

    goBalto speeds clinical trials through site selection, feasibility, activation and into conduct — getting needed therapies to patients sooner, like our namesake, Balto.

  • Next-Generation Solutions To Accelerate Clinical Study Startups
    Next-Generation Solutions To Accelerate Clinical Study Startups

    We develop next-generation solutions that simplify and accelerate clinical study startup in the pharmaceutical, biotechnology, and medical device industries. Our management team has over 100 years of combined experience in the life sciences industry and enterprise software implementation. Our team has worked for such companies as Amgen, Genentech, Quintiles, Roche, Johnson & Johnson, and Model N.

More From gobalto videos